Key Technologies

Sl. No:

Title

Licensed Out or Not

1

Uttroside B and derivatives thereof as therapeutics for hepatocellular carcinoma.

YES

2

A mouthwash composition for managing oral mucositis, process and methods thereof.

YES

3

Monoclonal Antibodies, Annexin V FITC, TRITC.

YES

4

Monoclonal Antibodies

YES

5

Monoclonal and Polyclonal Antobodies against Corona Virus SARS-Cov 2.

YES

6

Viral transfer media,RNA extraction Kit, Rapid Antibody Test (covid 19 based kits).

YES

7

Cell Lines.

YES

8

Covid 19 Anosmia Kit.

YES

9

Methods and materials for identifying therapeutic response in chronic myeloid leukemia.

NO

10

Polypeptides for managing viral infections.

NO

11

Therapeutic compositions from Brevenin-1 family of peptides and uses thereof.

NO

12

Therapeutic compositions of Antimicrobial Peptides.

NO

13

Peptides and uses for managing Viral Infections.

NO

14

Synthetic Transmembrane Peptide Pores for the Single-Molecule Sensing.

NO

15

Method for increasing biomass of Photosynthetic organism by extending its life in Culture.

NO

16

An Antifungal Synthetic Peptide Derived from Osmotin Protein.

NO

17

Apoptosis Inducing Peptide (SSTP1).

NO

18

Synthetic Hybrid Peptide Carrying Sprayable Hydrogel Delivery System for Chronic Wound Healing and Skin Regeneration.

NO

19

A Cu(II) carbohydrazone complex, processes, compositions, and applications thereof.

NO

20

A hexane extract of Aegle marmelos fruit and process thereof.

NO

21

A method of detecting and quantifying the calcium conducting activity of calcium channel proteins.

NO

22

Novel Tacrine Derivatives that target NMDA receptor, Acetylcholinesterase, Butyrylcholinesterase and Beta secretase activities.

NO